← Biohacking Beauty: The Anti-Aging Skincare Podcast
Biohacking Beauty: The Anti-Aging Skincare Podcast
Brianna Stanko: Are Budget Skincare Products Costing Your Skin’s Health?
00:15:42
Loading summary
Transcript19 lines
- [00:07]
A
You know, we are dealing with this now with spermidine. Like spermidine is a molecule that actually alone in, in a vacuum, it doesn't work well because it needs its friends. It needs the different types of, of things that your body uses in order to create spermidine, similar to cbd full spectrum and isolate. So spermidine in its natural form is 10 times stronger. So we know, because we do R and D for other companies. So we know also that realm and we see companies that are going to come with spermidine products but they're going to be significantly less expensive because they're using the isolated version and they're going to pay significantly less. And the customer either is going to be happy with buying something for less money or the customer is going to basically not see results. But at least we got their money like once or twice, right? They give us, they give us some money. That's really what they care about. The reason you need, you know, millions upon millions upon millions upon millions of dollars of budget, ad budget, it's because you, you're letting people down. So often. All you need find new people. Yeah, yeah, yeah, yeah. You know, they say soccer is new, soccer is born every day. That's what these companies are, are planning on.
- [01:23]
B
Right?
- [01:23]
A
The really big companies. The really big companies. So this is, I would say the. What's the name of like a big company that, that sells less expensive products. Like big, big company. I'm blanking, blanking on there. But like they're, they're, they're more, they're more expensive companies called Niode. N I O D. Yeah, that's the.
- [01:41]
B
Same as, Aren't they affiliated with the Ordinary?
- [01:44]
A
That's what I meant. That's what the Ordinary is doing. The Ordinary is, is, is. I mean, I think, by the way, shout out to niod. I think it's a great product. Okay, I want to say that. But they're, but they're basic, the ordinary product. That's what they're going to do. They're going to tell you 8% hyaluronic acid. Within that 8%, only 2% is going to be actually hyaluronic acid. Or they're going to make, you know, 2 million bottles of the product and the product's going to sit so long on a shelf that by the time you're getting it, it's significantly lower in active ingredients.
- [02:14]
B
Yep.
- [02:14]
A
But really big companies don't even have.
- [02:17]
B
Like anything to staple the ingredients. They don't have delivery systems. And people don't realize they're like, oh, I'm, I'm seeing these actives in here, but there's nothing to keep them stable and they have no delivery system. So yeah, you're paying $8 for a serum, but it's not doing anything. Like if you would actually invest in something with, you know, the right stabilization for that ingredient, the right delivery system, that makes all the difference.
- [02:39]
A
Listen. Yeah, but I'm going to play devil's advocate. You know, 30% is placebo. So three people are actually getting results, you know, so, so, and that's just because they have a good story. So, you know, take it or leave it. I think there is a place for, for an $8 product or a $10 or $20 product in the market. And I also think that there should be an alternative because I don't want people to look at it. You know, we are the cutting edge, right? Our you3 set serum is $195. Believe me, if I could make it cheaper, I would. But there is no way to make it cheaper or we can go into ingredients and I would break down. So we provide you to your skin the same amount of spermidine that you would buy in an $80 a month supplement. Nad the same amount that you're going to buy for $80 supplement. You know, you already have $160 there of, you know, a different brand. We have ergothioneine or thymine. Costs about $5,500 a liter. You know, some of my products too.
- [03:45]
B
It's expensive.
- [03:47]
A
You know, shout out to a company from France called Barnett that makes it. But Barnett, you know, are, are, are, you know, we have a representative meeting with them now in France. They're, they're skincare mafia I call them, right? They, they, they, they own an ingredient and they, and they have a chokehold on the brand, by the way. Ergothioneine, great, great product. But the list goes on and on and on. You know, I didn't even talk about like peptides, which again, we use patented versions of peptides because we want to make sure they work right. Even though I'm not a big peptide proponent. I know but, but they, you know, Argirelin, for example, is a peptide that, that is patented. It means there is a company that takes a premium on that, so on and so on and so on. So what is a, you know, company like the ordinary is going to do? Either they're going to use like peptides that, the, that the, that are not that great and no one renewed their patent like Matrixyl Family or you know, other peptides that are less effective, right? Or, or they're going to create complexes basically that inflate the amount that you think you're getting there. And again, three out of people, three out of 10 people get some results because they believe that, you know, the product. There is a placebo effect there. In skincare also, obviously we have polymers, we have stuff like that give you the, that give you the semblance of results. Now the really big companies, they're really, really, really big companies. L'Oreal, Estee Lauder. I always, always give the Estee Lauder example that in 2019 Estee Lauder came and basically had an, a crazy marketing campaign like, again, like tens of millions of dollars spent only on, on Macy, Mark Macy's marketing in Macy's. And they came out with a, with a product based on what was their amazing ingredient? Turmeric. And you're thinking, oh my God, I've known about turmeric for like a hundred years. Well, the reason I love giving that example, it's because this is where the median person that is, you know, is trying to look better. That's the new molecule they've heard about. Everyone listening to this, to this live on Instagram, if you've known about turmeric for before 2019, congratulations, you are actually ahead of the curve. So that is when, you know, Estee Lauder deemed that turmeric is ready for primetime. By the way, they are correct. Ayurvedic skin care companies that now make bank, I'm telling you, did not do it and shut down and were a flop prior to those to the early 2000 and twenties. So really big companies try to find what the lowest hanging fruit is and then the, you know, the amazing marketing machine is going to pump that out. So I'm assuming that probably within like three, four years we're going to see the big, you know, peptide discussion, what we think. Now, you know, you listen to me and I'm telling you, people are trying to sell you peptides as the, as a silver bullet. And I'm telling you, hey Peptides, if you really want them to work, you better inject them or in some cases take them as a pill. Don't get excited when you hear about it in skin care. Everyone listening, everyone that agrees doesn't agree with me. We're all in the same boat. We're all way ahead of the curve. So that's kind of an idea where, where companies are at. We are so esoteric, right? Yungoos is an esoteric company. Okay. What we care about is, is to be right as far as like to, to, to treat yourselves right. And that is why we are still a company that not a lot of people know know because that's not, not a very, you know, we don't have, we don't have 50 millions to spend on Macy's. Yeah, I don't know if you want to spend anything in Macy's right now.
- [07:43]
B
But yeah, yes, I know. I, I, I love everything, everything that, that you guys are about. Where do you guys see young Jews going in the future then? How do you guys, you know, what advancements are you doing? What are you guys planning? You know, where are you taking the brand?
- [07:57]
A
Okay, a short answer is biologics, exosomes and things like that. We already obviously are pioneers in biomimetic lipids, which is like super important. People probably know ceramides and things like that. But really again, ceramides is the low hanging fruit. We can actually mimic cholesterol. We can mimic different fats that are living on the top of your skin and make up your skin barrier. And we have it in many of our formulations. That's what carry carries nad nanoparticles or micronized particles into your skin. That's what carries our retinol for example into your skin, etc. But we are going to get into the exosomes space and this is a whole new discussion. But exosomes right now people need to understand exosomes are, it's like saying liposomal, right? If I have, if I, if I'm telling you my product is liposomal, I don't know if you're going to, you should not get excited because you're going to tell me liposomal what, what are you providing me with? So every, every skincare company under the sun, I know you just launched a company that I love which is called plated, right? You started selling them shout out to plated. Great product. But Plated, which has about a trillion exosomes in their, the more concentrated like 15ml product, they say, hey, we actually don't know what information our exosomes carry. We know a lot of it is good and I agree with their assessment. But we would need literally to go into millions and millions of dollars of research which instead of again pushing our products to the knowledge of more people, we're going to have to now spend it on, on being, being treating you right, which is very difficult. It's a very difficult decision to make, especially if you have a good product. Hey, we know the product is good, leave us alone. So you know what we are doing? We took our time with exosomes because again, I want to say on a personal level I thought the FDA is going to shut exosomes down. So we have been doing research around exosomes Happen.
- [09:55]
B
What do you still feel like that's going to happen?
- [09:57]
A
That's a no, no, no. It is always a possibility. But we were waiting for September to explain what's going on. So in September the FDA had stricter regulations around labels. So you saw a lot of companies kind of change their labels a little bit around September or before because they were getting ready for it. And we thought the FDA is going to see the amount of misinformation around biologics and is going to, and basically is going to shut down the idea of using human derived.
- [10:25]
B
Right.
- [10:26]
A
Or animal derived exosomes, which is different than then plant derived exosomes. Plant derived exosome. I'm not even going to merit any, any, any of my vocal cords to explain. But this is, this is more BS it's like plant stem cells. Okay, it's BS beyond BS but that's why we took our time and we are going to launch later on a 2 trillion exosomes per 15 milliliters product. But we will make sure we say hey, this is the amount of a specific growth factor that is carried there or anything like that. And we, we're working very hard because exosomes and NAD are not, not the best of friends. So we need to make sure that they, that they work well together because that's part of what we want. Okay, now that was my small rant about the future. But the bigger thing that I feel that, that we're going to be doing and I think we, I think we hear often about personalized skincare. Correct me if I'm wrong, especially by the way, if anyone likes AI and ChatGPT. Ask ChatGPT what the future of skincare is. It's going to tell you personalized skincare. But the problem is, is that you, you will never, you will, you will never have. Not never, but it's going to be a long, long time until you have skin care that is specifically made for you. When a company says, hey, fill up this whatever, spit into this vial, whatever that is and we're going to make you a skincare product, they're lying. They have a certain amount of formulas and then they stick your name on it, then they send it to you. But what you can do is create products that fit through again through big data and machine learning fit products to your specific needs. And what we're going to do, what we're going to launch and this is actually we needed to, to register it with the FDA as a, as a medical assessment, analysis and and recommendation. We're going to launch a metabolomics test. It's a, basically it's a you, you prick your finger like you test your insulin and or your, or your ex or your ketone levels basically like you know, if you are on a ketogenic diet, you touch a piece of pad and you send that pad. Everything is obviously in a box and what we're going to analyze are different molecules in your dry blood spot that tell us what is the health and kind of biological age and everything that's associated with your skin. What, what your skin needs in order to function on a, on a more younger, in a more young, younger state. That might be your again your mitochondria that might be NAD levels that might be against. We test spermidine there. We also test things like you know, different types of vitamin C components which are important for collagen production, et cetera, et cetera, et cetera. So we test out 19 different components that your skin needs in order to function optimally. And then we tell you hey, here are the Yungoos products that are going to make sure that we fill in all these gaps aside from creating a again better skin through youthful function but also making sure that your gaps are filled. And this is going to be, that's going to be the first test metabolomics test, skin specific metabolomics test in the world. And this is going to be the first real personalized skincare test and actionable results in the world. And by the way, you people could probably, probably buy it in Skin Truth and that's pretty easy to do. It's all through AI. Very easy. Yeah.
- [14:06]
B
That's amazing. So cool. Like I said, your brand is so, so interesting, so unique. I'm so glad that I found it personally and I get to share it with everybody that listens to me because you have great, you have great products and just great different science behind them. So I love that.
- [14:24]
A
Yeah, thank you very much. Last, I think what we're really interested in is the, is the intersection between red light therapy. As you know, that's where I'm coming from and DNA repair. So probably, you know, in the next two months we're going to launch a new. We have the Green Tea Phyto serum that increases red light therapy efficacy. But we're going to have a completely different, you know, version of it that has DNA repair enzymes that are activated by red light. And, you know, when we have DNA repair enzymes right now in skincare, the problem is that, like, 99% of them, they don't actually. They get activated or they're already active and they're kind of. They don't get to where we need repair. So by applying something and waiting, you know, one minute until it gets absorbed to where it needs to get deeper into the skin, and then we activate it with red light, we can have significantly more profound DNA repair.